#PharmaceuticalIndustry

Η Ναυτεμπορική 3w

Deputy Minister of Development Stavros Kalafatis highlighted that Greece produces a significant portion of Europe's oncology (50%), cardio-metabolic (30%), and penicillin (25%) drugs, emphasizing the importance of collaboration between the state, industry, and research sectors in driving innovation and sustainable growth within the healthcare industry. #InnovationInHealthcare #PharmaceuticalIndustry #ResearchAndDevelopment

Kalafatis: Greece produces 50% of Europe’s oncology drugs, 30% of cardio-metabolic drugs and 25% of penicillin drugs

SILVANO TROTTA OFFICIEL 3w

(TR) Stefan Oelrich is a high-ranking German executive in the pharmaceutical industry. He spoke about Covid vaccines: "Ultimately, mRNA vaccines are an example of this cellular and gene therapy. I always like to say: if we had polled the public two years ago...

SILVANO TROTTA OFFICIEL 3w

(TR) The crisis actor Jake Rosemarin, who was aboard the cruise ship with Hantavirus and was shooting a video about COVID, also worked in the pharmaceutical industry and promoted the COVID vaccine. A paid agent who can be unmasked in a few...

Investing.com Español 4w

Alemania está implementando reformas drásticas para abordar un creciente déficit en sus fondos de seguro médico, lo que incluye estrictas regulaciones de precios y descuentos en medicamentos, lo que podría perjudicar la industria farmacéutica y afectar el acceso a innovaciones médicas. #HealthcareReform #PharmaceuticalIndustry #CostReduction

La farmacia alemana ante un aprieto "histórico": Merz apunta a un déficit de 40.000 millones Por Investing.com

R

Reuters 4w

The California Supreme Court is set to review whether drug manufacturers like Gilead Sciences have a legal obligation to continue developing allegedly safer alternatives for their products, following a case where 24,000 HIV patients claim Gilead neglected to pursue a newer drug with fewer side effects in favor of maximizing profits from an existing medication. #PharmaceuticalIndustry #ProductLiability #Innovation #US

California's highest court to consider whether drugmakers have 'duty to innovate'

BBC May 2

AstraZeneca has announced a £300 million investment in UK drug development, reversing a previous decision to pause investment in Cambridge, which is expected to boost local employment and enhance patient access to clinical trials, amid changes in pharmaceutical pricing agreements between the UK and US. #PharmaceuticalIndustry #Investment #LifeSciences #UK #US

What does AstraZeneca's £300m pledge for UK mean for Cambridge?

Deutsche Welle Apr 13

An international investigation reveals that Merck's commercial strategy for its cancer drug Keytruda, which costs over R$20,000 in Brazil, employs complex legal and pricing tactics to control access, thereby making it increasingly inaccessible to many patients worldwide, despite its significant role in treating various cancers and generating billions in revenue. #CancerTreatment #PharmaceuticalIndustry #HealthInequality

Como um remédio de ponta contra câncer se tornou inacessível

Deutsche Welle Apr 13

An international investigation reveals that pharmaceutical company Merck's commercial strategy for the cancer drug Keytruda has been obstructing access to treatment for many patients worldwide due to its exorbitant pricing and extensive patent protections. #CancerTreatment #PharmaceuticalIndustry #PatientAccess